At the Scottish research conference Dr Shuko Joseph, Clinical Research Fellow at the University of Glasgow, will present an update on the important research she has been leading to understand the effect of Duchenne muscular dystrophy on bone health.
Over the past three years we have been delighted to work alongside a wide range of organisations and individuals to lead the way in improving the specialist care and support available to people with muscle-wasting conditions.
Thank you to all of these organisations and the many others we have worked alongside to help secure almost £4 million of new NHS investment in neuromuscular specialist roles and equipment across the UK. ... See MoreSee Less
#creativeportraitmagazine #issue16 has landed ! ** share with your creative team, friends & family! ** <3 To order your print copy: Paypal: email@example.com £13.00 Quoting "Issue 16" when ordering Please be sure to leave your address
All profit from sales of printed magazines go straight to Muscular Dystrophy UK to help fund vital research into finding a cure for the debilitating muscle wasting disease.
Thank you to all who submitted Enjoy ! Gems & #teamcreative :-) ... See MoreSee Less
Cover featuring: Photographer Daniel Moncur-Sime
with Models Tania Davies & Tara Summer
We are Portrait.Fashion.Beauty & Editorial in aid of Muscular Dystrophy UK
A new study has shown that mitochondrial replacement therapy has the potential to reduce the risk of a mother passing on mitochondrial disease to her children. The therapy, also called mitochondrial donation IVF, has been approved in the UK and could be used in clinics following an application to the Human Fertilisation and Embryology Authority (HFEA) for a licence on a case-by-case basis. Find out more about the study here >> qoo.ly/99kev. ... See MoreSee Less
A new study published in the scientific journal Cell Stem Cell shows that a new IVF technique developed to prevent the passing on of mitochondrial diseases from mother to child might carry a low risk ...
“There is a drug called Eteplirsen that could keep my muscles stronger for longer. Please help us campaign and get the drug approved.”
It was announced this week that the US Food and Drug Administration has put back its decision on approval for Duchenne drug, Eteplirsen, a treatment which could help children like 12-year old James Barr. Get further news here >> qoo.ly/99jb8. ... See MoreSee Less